- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Vietnam has a concentrated HIV epidemic, with the highest HIV prevalence being observed among people who inject drugs (PWID). Based on its experience scaling-up robust HIV interventions, Vietnam aims to further strengthen its response by harnessing the preventive benefits of antiretroviral therapy (ART). Mathematical modelling suggests that prioritizing key populations for earlier access to ART, combined with other prevention interventions, may have significant impact on the epidemic, cost-effectively reducing new HIV infections and deaths. Pilot studies are being conducted to assess feasibility and acceptability of expansion of HIV testing and counselling (HTC) and early ART among key populations and to demonstrate innovative service delivery models to address challenges in uptake of services across the care cascade. Earlier access of key populations to combination prevention interventions, combined with sustained political commitment and supportive environment for key populations, are essential for maximum impact of ART on the HIV epidemic in Vietnam.
Keywords: Antiretroviral therapy, HIV prevention, Concentrated epidemic, Vietnam, People who inject drugs
Abundant evidence shows that harm reduction programmes can significantly reduce HIV transmission among people who inject drugs. Several countries are demonstrating the benefits of actively scaling up quality programmes that are based on human rights and public health needs.
The Guidelines aim to support countries provide more effective and comprehensive HIV services for the key populations, including men who have sex with men (MSM) and transgender people and include discussion of specific issues relating to adolescent key populations. Although, there is still a lack of evidence to support recommendation of PrEP to transgender women. In this brief we highlight the recommendations made in the Guidelines that are most relevant to MSM and transgender people.
Regional Posters prepared by
Keywords: Ending AIDS, 2030, 90-90-90, treatment, men who have sex with men (MSM), Sex work, people who inject drugs (PWID)
Afghanistan is the world’s largest producer and cultivator of opium poppies; it produces almost three quarters of the world’s illicit opium. While a significant amount of the opium produced in Afghanistan is trafficked out of the country, in 2009 it was estimated that almost 10 per cent of Afghans aged between 15 and 64 were drug users.
This document develops core arguments for why it is relevant, feasible, and indeed crucial to include people who inject drugs in national treatment guidelines and programs for chronic HCV infection – from both public health and human rights perspectives.
This report presents the key findings and recommendations of the review of Myanmar's legal framework and its effect on access to health and HIV prevention and treatment services for people living with HIV and key affected populations.
Keywords: Myanmar, Legal, PLHIV, Sex workers, MSM, Transgender, Women, Girls, Children, Young people, Key populations
This policy brief provides an overview of key findings, data and figures of the new consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. In addition, it offers an overview of the comprehensive package on interventions and a table summarizing WHO recommendations concerning key populations.
Keywords: HIV, men who have sex with men (MSM), people who inject drugs (PWID), sex workers, transgender, testing, treatment
This policy brief aims to promote the realization of gender equality and human rights in terms of an effective harm reduction response to HIV for women who inject drugs in community and prison settings. It outlines a framework to achieve that goal which focuses on improving the availability, accessibility, affordability and acceptability of women-oriented harm reduction interventions. Suggested good practice tools and guidance are also provided.
The Global State of Harm Reduction 2014 maps the response to drug-related HIV, viral hepatitis and tuberculosis. It also integrates updated information on harm reduction services into each regional chapter, including on needle and syringe programmes (NSPs) and opioid substitution therapy (OST) provision; harm reduction services in the prison setting; access to antiretroviral therapy for people who inject drugs; regional overdose responses; policy developments; civil society developments; and information relating to funding for harm reduction.